Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 5
Submit an article Journal homepage
4
Views
1
CrossRef citations to date
0
Altmetric
Articles

The relationship between early recanalization and serum NT-proBNP levels in patients with a first ST-segment elevation myocardial infarction treated with primary coronary angioplasty

Iwona SzadkowskaInvasive Cardiology Unit, Ist Department of Cardiology and Cardiosurgery, Medical University of Lodz, Poland.Correspondence[email protected]
,
Jan Henryk GochCardiology Clinic, Ist Department of Cardiology and Cardiosurgery, Medical University of Lodz, Poland.
,
Lukasz PolakCardiology Clinic, Ist Department of Cardiology and Cardiosurgery, Medical University of Lodz, Poland.
,
Henryk StepienEndocrinology Clinic, Medical University of Lodz, Poland.
&
Krzysztof ChizynskiInvasive Cardiology Unit, Ist Department of Cardiology and Cardiosurgery, Medical University of Lodz, Poland.
Pages 479-484 | Received 12 Mar 2007, Accepted 27 Jun 2007, Published online: 23 May 2017

References

  • Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82–91.
  • Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Clop-ton P, Gardetto N, Morrisey R, Garcia A, Chiu A, De Maria A. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001; 141: 367–74.
  • Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Frampton C, Crozier IG, Smyth DW. Neu-roendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart 1999; 81: 114–20.
  • Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J2005; 26: 1115–40.
  • Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, Daikoku S, Matsumoto T, Miyazaki S, Matsuoka H, Takishita S, Kangawa K, Matsuo H, Nonogi H. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 1998; 135: 21–8.
  • Talwar S, Squire TB, Downie PF, Mccullough AM, Camp-ton MC, Davies JE, Barnett DB, Ng LL. Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. Eur Heart J2000; 21: 1514–21.
  • Groenning BA, Nilsson JC, Sondergaard L, Pedersen F, Trawinski J, Baumann M, Larsson HB, Hildebrandt PR. Detection of left ventricular enlargement and impaired sys-tolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 2002; 143: 923–9.
  • Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, Mannucci PM, Mininni N, Prando MD, Tubaro M, Vernocchi A, Vecchio C. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circula-tion 2004; 110: 128–34.
  • Bazzino 0, Fuselli JJ, Botto F, Perez De Arenaza D, Bahit C, Dadone J. Relative value of N-terminal probrain natri-uretic peptide, TIMI risk score, ACC/AHA prognostic clas-sification and other risk markers in patients with non-ST-ele-vation acute coronary syndromes. Eur Heart J2004; 25: 1-8.
  • James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Calif R, Topol EJ, Simoons ML, Wallentin L. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mor-tality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003; 108: 275–81.
  • Lang MR, Bierig M, Devereux RB, Flachskampf FA, Fos-ter E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, Sutton MJ, Stewart W. Recommendations for chamber quantification. Eur J Echo cardio gr 2006; 7: 79–108.
  • Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic per-formance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005; 11(5 Suppl): S15-20.
  • Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic eval-uation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004; 90: 297–303.
  • Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AR Use of B-type natriuretic peptide in the evaluation and manage-ment of acute dyspnea. N Engl J Med 2004; 350: 647–54.
  • Januzzi JL, Camargo CA, Anwaruddin S. Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melan-son S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948–54.
  • Crilley JG, Farrer M. Left ventricular remodeling and brain natriuretic peptide after first myocardial infarction. Heart 2001; 86: 638–42.
  • Inoue T, Sakuma M, Yaguchi I, Mizoguchi K, Uchida T, Takayanagi K, Hayashi T, Morooka S. Early recanaliza-tion and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction. Am Heart J2002; 143: 790-6.
  • Hartmann F, Kurowski V, Maghsoudi A, Kurz T, Schwarz M, Bonnemeier H, Tölg R, Jain D, Wiegand U, Katus H, Richardt G. Plasma catecholamines and N-terminal proBNP in patients with acute myocardial infarction under-going primary angioplasty. Relation to left ventricular func-tion and clinical outcome. Z Kardiol 2003; 92(1): 73–81.
  • Gill D, Seidler T, Troughton RW, Yandle TG, Frampton CM, Richards M, Lainchbury JG, Nicholls G. The vigor-ous response in plasma NT-proBNP to acute myocardial infarction. Clin Sci (Lond) 2004; 106(2): 135–9.
  • Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG. B-type natriuretic peptides and ejection frac-tion for prognosis after myocardial infarction. Circulation 2003; 107: 2786–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.